Search Results for " Abemaciclib "
Abemaciclib Related Products
Abemaciclib is a medication for the treatment of advanced or metastatic breast cancers. Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 (CDK4) and 6 (CDK6) that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. It was designated as a breakthrough therapy for breast cancer by the US Food and Drug Administration (FDA).
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Abemaciclib, pharmacopeial and non-pharmacopeial Abemaciclib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Abemaciclib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Abemaciclib-related products are thoroughly characterized. Abemaciclib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.